Journal
AMERICAN JOURNAL OF PATHOLOGY
Volume 176, Issue 5, Pages 2490-2499Publisher
ELSEVIER SCIENCE INC
DOI: 10.2353/ajpath.2010.090777
Keywords
-
Categories
Funding
- NIH [RO1CA116092, RO1CA107181, R01AT004294, R01CA137037]
- Louisville Veterans Administration Medical Center
- Susan G. Komen Breast Cancer Foundation
Ask authors/readers for more resources
In this study we observed that mice pretreated with tumor exosomes had a significant acceleration of tumor metastasis in the lung. Tumor metastasis correlated significantly with an increase in recruitment of more Myeloid-derived suppressor cells (MDSCs) in the lung of C57BL/6j (B6) mice pretreated with tumor exosomes. These effects were blunted when MyD88 knockout (KO) mice were pretreated with tumor exosomes. MDSCs induced by tumor exosomes and isolated from wild-type B6 mice also more potently inhibited T cell activation and induction of interleukin-6 and tumor necrosis factor-alpha than MDSCs isolated from the lung of MyD88 KO mice. In vitro, addition of tumor exosomes to bone marrow-derived CD11b(+) Gr-1(+) cells isolated from wild-type B6 mice resulted in more cytokine production, including tumor necrosis factor-alpha, interleukin-6, and the chemokine CCL2, than CD11b(+)Gr-1(+) cells isolated from MyD88 KO mice. Moreover, lower levels of CCL2 were observed in the lungs in MyD88 KO mice pretreated with tumor exosomes than that in wild-type mice. Together these data demonstrate a pivotal role for MyD88 in tumor exosome-mediated expansion of MDSCs and tumor metastasis. (Am J Pathlo 2010, 176:2490-2499; DOI: 10.2353/ajpath.2010.090777)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available